Cord Blood Banking with ViaCord
Every month thousands of parents choose to bank their newborns cord blood. Why?
Cord blood stem cells are doing amazing things right now – helping treat serious diseases and changing lives for the better. And the potential of cord blood stem cells continues to be explored with clinical trials underway for serious health conditions such as Cerebral Palsy, Autism and Type 1 Diabetes1
For over twenty years, ViaCord has been providing high quality, umbilical cord blood stem cell collections for families – processing and storing the cord blood of more than 350,000 newborns. Now here’s your chance to make cord blood banking a part of your family plan.
One Winner will be selected to receive the following Cord Blood banking services, for a single birth, from ViaCord free of charge: processing, shipping by courier and first year storage (approximate total value of $1,375). The Winner is responsible for all storage and other fees and costs related to the banking of their baby’s cord blood that are not specifically set forth in the prior sentence. These include, without limitation, the responsibility for paying $175 per year to cover annual storage fees after the first year of storage, any fees related to the release of the cord blood unit for transplant, and any fees related to the delivery or collection of the cord blood unit imposed by third parties.
All federal, state and local taxes related to receiving the Prize are the sole responsibility of the Winner. Odds of winning depend on the number of eligible entries. ViaCord will not award any alternative prize, cash equivalent, or any other substitution of the Prize if, for any reason, the cord blood collection, processing or storage cannot take place. The Prize is non-transferable. By entering the contest, entrants agree to have their submitted name displayed on Facebook, Twitter, ViaCord’s Facebook fan page and ViaCord’s website, and used by ViaCord for any purpose, at any time, without any fee or other form of compensation. ViaCord reserves the right to disqualify users, without notice,and for any reason.
Employees, officers, and directors of ViaCord, its parent companies, affiliates, subsidiaries, advertising, promotion, and fulfillment agencies, and legal advisors, and their immediate family members and persons living in their same household are not eligible to participate in the Giveaway. All federal, state, and local laws and regulations apply. Void wherever prohibited or restricted by law. ViaCord and PerkinElmer employees, as well as their immediate family members are not eligible, i.e. spouse, sibling, child, etc. Health Care Professionals (HCPs) are not eligible. HCPs include physicians, nurses, nurse practitioners, medical students, and other professionals with prescribing authority, pharmacists, receptionists or medical office employees. By entering the giveaway, you accept these terms and conditions and thus you certify that you are not an HCP.
By entering the contest, entrants agree to have their submission, including name, displayed on any or all of ViaCord’s social channels, including but not limited to: Facebook, Twitter, Google+, Instagram, , Tumblr; also on ViaCord’s website. ViaCord has the right to use submissions for any purpose, at any time, without any fee or other form of compensation. ViaCord reserves the right to disqualify users, without notice, and for any reason. By accepting a Prize, the Winner grants Sponsor the use of his/her name, voice, hometown and likeness for the purpose of advertising, trade, or promotion without further compensation, unless prohibited by law.
Disclaimer: Banking cord blood does not guarantee that treatment will work and only a doctor can determine when it can be used. Cord tissue stem cells are not approved for use in treatment. For more details and references, click here.
Visit viacord.com for more information. And connect with ViaCord:
1. Harris DT, Badowski M, Ahmad N, Gaballa MA. The potential of cord blood stem cells for use in regenerative medicine. Expert Opin Biol Ther. 2007;7(9):1311–1322. National Institutes of Health, ClinicalTrials.gov. Umbilical cord blood infusion to treat type 1 diabetes. http://clinicaltrials.gov/ct2/show/NCT00305344. Accessed September 11, 2012. National Institutes of Health, ClinicalTrials.gov. A randomized study of autologous umbilical cord blood reinfusion in children with cerebral palsy. http://clinicaltrials.gov/ct2/show/NCT1147653. Identifier NCT01147653. Accessed September 11, 2012
Disclosure: This is a sponsored post.
a Rafflecopter giveaway